| scholarly article | Q13442814 |
| P50 | author | Brett M Paterson | Q56855593 |
| Cinzia Imberti | Q58522338 | ||
| Philip J Blower | Q60617592 | ||
| P2093 | author name string | Michelle T Ma | |
| Robert C Hider | |||
| Calum A Foley | |||
| Jennifer D Young | |||
| Yifu Wang | |||
| Yu-Lin Chen | |||
| P2860 | cites work | The gallium-deferoxamine complex: stability with different deferoxamine concentrations and incubation conditions | Q77325829 |
| TRAP, a powerful and versatile framework for gallium-68 radiopharmaceuticals | Q82836384 | ||
| How is (68)Ga labeling of macrocyclic chelators influenced by metal ion contaminants in (68)Ge/(68)Ga generator eluates? | Q85390972 | ||
| Systematic comparison of the mono-, dimethyl- and trimethyl 3-hydroxy-4(1H)-pyridones - Attempted optimization of the orally active iron chelator, deferiprone | Q89062664 | ||
| Determination of the intrinsic site pK(a) value and cooperativity of the symmetrical hexadentate chelator N,N',N''-tris[2-(3-hydroxy-2-oxo-1,2-dihydropyridin-1-yl)acetamido]ethylamine. | Q52338740 | ||
| GLEE, a new computer program for glass electrode calibration. | Q52850633 | ||
| PET imaging with a [68Ga]gallium-labelled PSMA ligand for the diagnosis of prostate cancer: biodistribution in humans and first evaluation of tumour lesions. | Q53131398 | ||
| In Vivo Characterization of 4 Ga-Labeled Multimeric RGD Peptides to Image αβ Integrin Expression in 2 Human Tumor Xenograft Mouse Models | Q57757467 | ||
| Structure and stability of hexadentate complexes of ligands based on AAZTA for efficient PET labelling with gallium-68 | Q60171678 | ||
| Radiogallium localization in tumors: blood binding and transport and the role of transferrin | Q71244210 | ||
| Synthesis, physicochemical properties, and biological evaluation of N-substituted 2-alkyl-3-hydroxy-4(1H)-pyridinones: orally active iron chelators with clinical potential | Q72889098 | ||
| Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones | Q77158406 | ||
| Investigation of equilibria in solution. Determination of equilibrium constants with the HYPERQUAD suite of programs | Q29012606 | ||
| Approaching 'Kit-Type' Labelling with (68)Ga: The DATA Chelators | Q30938260 | ||
| Iron binding dendrimers: a novel approach for the treatment of haemochromatosis | Q33248894 | ||
| Technetium and gallium derived radiopharmaceuticals: comparing and contrasting the chemistry of two important radiometals for the molecular imaging era. | Q34111790 | ||
| Underscoring the influence of inorganic chemistry on nuclear imaging with radiometals | Q34119201 | ||
| Complexation of metal ions with TRAP (1,4,7-triazacyclononane phosphinic acid) ligands and 1,4,7-triazacyclononane-1,4,7-triacetic acid: phosphinate-containing ligands as unique chelators for trivalent gallium. | Q34119384 | ||
| Tripodal tris(hydroxypyridinone) ligands for immunoconjugate PET imaging with (89)Zr(4+): comparison with desferrioxamine-B. | Q35170338 | ||
| Rapid kit-based (68)Ga-labelling and PET imaging with THP-Tyr(3)-octreotate: a preliminary comparison with DOTA-Tyr(3)-octreotate | Q36143456 | ||
| New Tris(hydroxypyridinone) Bifunctional Chelators Containing Isothiocyanate Groups Provide a Versatile Platform for Rapid One-Step Labeling and PET Imaging with (68)Ga(3.). | Q36595679 | ||
| Comparison of PET imaging with a (68)Ga-labelled PSMA ligand and (18)F-choline-based PET/CT for the diagnosis of recurrent prostate cancer | Q37350456 | ||
| Prospective of ⁶⁸Ga-radiopharmaceutical development | Q37435222 | ||
| Efficient bifunctional gallium-68 chelators for positron emission tomography: tris(hydroxypyridinone) ligands | Q37594420 | ||
| Enhancing PET Signal at Target Tissue in Vivo: Dendritic and Multimeric Tris(hydroxypyridinone) Conjugates for Molecular Imaging of αvβ3 Integrin Expression with Gallium-68. | Q37648915 | ||
| Positron emitting [68Ga]Ga-based imaging agents: chemistry and diversity | Q37895281 | ||
| Matching chelators to radiometals for radiopharmaceuticals | Q38156660 | ||
| A nuclear chocolate box: the periodic table of nuclear medicine. | Q38269216 | ||
| Continued rapid growth in (68) Ga applications: update 2013 to June 2014. | Q38358666 | ||
| 68Ga-THP-PSMA: A PET Imaging Agent for Prostate Cancer Offering Rapid, Room-Temperature, 1-Step Kit-Based Radiolabeling | Q38707752 | ||
| Equilibrium, Kinetic and Structural Properties of Gallium(III) and Some Divalent Metal Complexes Formed with the New DATAm and DATA5m Ligands. | Q38786041 | ||
| 68Ga-complex lipophilicity and the targeting property of a urea-based PSMA inhibitor for PET imaging | Q39389586 | ||
| National Electrical Manufacturers Association NU-4 performance evaluation of the PET component of the NanoPET/CT preclinical PET/CT scanner | Q40001502 | ||
| A triazacyclononane-based bifunctional phosphinate ligand for the preparation of multimeric 68Ga tracers for positron emission tomography. | Q42167262 | ||
| Acyclic chelate with ideal properties for (68)Ga PET imaging agent elaboration | Q42854505 | ||
| Amido-3-hydroxypyridin-4-ones as iron(III) ligands | Q43097060 | ||
| Fusarinine C, a novel siderophore-based bifunctional chelator for radiolabeling with Gallium-68. | Q43125421 | ||
| Design, synthesis, and evaluation of novel 2-substituted 3-hydroxypyridin-4-ones: structure-activity investigation of metalloenzyme inhibition by iron chelators | Q43863758 | ||
| Emerging understanding of the advantage of small molecules such as hydroxypyridinones in the treatment of iron overload | Q44392273 | ||
| Simple, mild, one-step labelling of proteins with gallium-68 using a tris(hydroxypyridinone) bifunctional chelator: a 68Ga-THP-scFv targeting the prostate-specific membrane antigen. | Q47105948 | ||
| Comparison of macrocyclic and acyclic chelators for gallium-68 radiolabelling | Q47195725 | ||
| Imaging Characteristics and First Experience of [68Ga]THP-PSMA, a Novel Probe for Rapid Kit-Based Ga-68 Labeling and PET Imaging: Comparative Analysis with [68Ga]PSMA I&T. | Q48221776 | ||
| PSA-stratified detection rates for [68Ga]THP-PSMA, a novel probe for rapid kit-based 68Ga-labeling and PET imaging, in patients with biochemical recurrence after primary therapy for prostate cancer | Q48297324 | ||
| Cold Kit PSMA PET Imaging: Phase I study of (68)Ga-THP-PSMA PET/CT in patients with prostate cancer | Q49547397 | ||
| P275 | copyright license | Creative Commons Attribution 3.0 Unported | Q14947546 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 4299-4313 | |
| P577 | publication date | 2019-03-01 | |
| P1433 | published in | Dalton Transactions | Q282900 |
| P1476 | title | Tuning the properties of tris(hydroxypyridinone) ligands: efficient 68Ga chelators for PET imaging | |
| P478 | volume | 48 |
| Q89879563 | Manipulating the In Vivo Behaviour of 68Ga with Tris(Hydroxypyridinone) Chelators: Pretargeting and Blood Clearance | cites work | P2860 |
Search more.